TianYu Bio-Technology Co

TianYu Bio-Technology Co Equity

The The Equity of TianYu Bio-Technology Co (603717.SS) as of Oct 17, 2026 is 412.42 M CNY. In the previous year, The Equity was 518.74 M CNY — a change of -20.50% (lower).

Equity

412.42 MCNY

YoY

-20.50%

Last updated:

In 2025, TianYu Bio-Technology Co's equity was 412.42 M CNY, a -20.50% increase from the 518.74 M CNY equity in the previous year.

The TianYu Bio-Technology Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
1.35 B CNY
Jan 1, 2019
1.41 B CNY
Jan 1, 2020
1.24 B CNY
Jan 1, 2021
1.42 B CNY
Jan 1, 2022
1.14 B CNY
Jan 1, 2023
645.66 M CNY
Jan 1, 2024
518.74 M CNY
Jan 1, 2025
412.42 M CNY
The TianYu Bio-Technology Co Equity history
YEAREquityYoY
412.42 MCNY-20.50%
518.74 MCNY-19.66%
645.66 MCNY-43.37%
1.14 BCNY-19.58%
1.42 BCNY+14.37%
1.24 BCNY-12.12%
1.41 BCNY+4.55%
1.35 BCNY+4.42%
1.29 BCNY+115.13%
600.61 MCNY+22.40%
490.70 MCNY+25.02%
392.49 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TianYu Bio-Technology Co Stock analysis

What does TianYu Bio-Technology Co do? TianYu Bio-Technology Co Ltd, identified by the ticker symbol 603717.SS and ISIN CNE1000030W1, is a corporate entity headquartered in Shanghai, China. Operating within the Industrials sector, the company is classified under the industry of Commercial Services & Supplies. As of the most recent data, the firm employs a workforce of 446 individuals. TianYu Bio-Technology Co Ltd officially entered the public markets through an Initial Public Offering on March 27, 2017. The company maintains a digital presence via its website at http://www.tygf.cn/. While the corporate name suggests a focus on bio-technology, the operational description provided indicates a primary engagement in ecological engineering construction, specifically concerning gardens, alongside comprehensive landscape planning and design services. The business activities are structured around three distinct operational segments. The first and most prominent segment is the Landscape Ecosystem Engineering division. This unit is primarily responsible for executing garden greening engineering projects. Furthermore, it handles the restoration of ecological wetlands, which involves rehabilitating natural water-based ecosystems. The scope of this segment also extends to municipal garden development and road greening initiatives, aiming to integrate green spaces into urban infrastructure. Additionally, the company undertakes the restoration of slopes and curbs, addressing both aesthetic and structural environmental needs. The second major segment is the Landscape Architecture Design division. This part of the business focuses on the creative and technical design of ecological garden engineering projects. It involves the planning and conceptualization phases necessary to bring ecological garden visions to life, ensuring that design principles align with environmental sustainability and aesthetic goals. The third segment, categorized as Other Business, encompasses ancillary operational activities. This includes the operation and management of construction maintenance services, ensuring that completed projects remain in optimal condition over time. It also involves the cultivation of nursery stocks, which provides the necessary plant materials for the greening and landscaping projects undertaken by the company. This vertical integration from design and cultivation to engineering and maintenance allows the company to manage the entire lifecycle of its ecological projects. The company's presence in Shanghai, a major economic hub, positions it within a dynamic market for urban development and environmental services. The combination of engineering, design, and maintenance services suggests a comprehensive approach to landscape and ecological management, catering to municipal and private sector clients seeking to enhance their environmental footprint through professional landscaping and ecological restoration. TianYu Bio-Technology Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing TianYu Bio-Technology Co's Equity

TianYu Bio-Technology Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding TianYu Bio-Technology Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating TianYu Bio-Technology Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

TianYu Bio-Technology Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in TianYu Bio-Technology Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about TianYu Bio-Technology Co stock

The Equity of TianYu Bio-Technology Co is 412.42 M CNY in 2025.

The Equity of TianYu Bio-Technology Co changed from 518.74 M CNY to 412.42 M CNY, representing a -20.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity TianYu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's TianYu Bio-Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — TianYu Bio-Technology Co

All Key Metrics — TianYu Bio-Technology Co